Prescribing information

 

Rate this content: 
No votes yet

Speak to a Novartis representative

Please complete this form to be contacted by a Novartis promotional representative in your area. For medical information, please contact our Medical Information team by email. Fields marked * below are mandatory.

Your information will be used to put you in contact with a Novartis representative and handled in accordance with our Privacy Notice.

UK | June 2021 | 119387

×

Ask Speakers

×

Medical Information Request

 

ADAKVEO® has a conditional marketing authorisation and further evidence is awaited.

For more information, refer to the ADAKVEO® ▼ (crizanlizumab) prescribing information available here:  https://www.health.novartis.co.uk/sites/health.novartis.co.uk/files/adak...

Legal Category: POM.

Marketing Authorisation (MA) number, quantities and price: EU/1/20/1476/001  £1,038.00 per 10ml vial

 

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]